Skip to content
Home›Awards›Teva Pharmaceuticals USA, INC.
$

Federal Contract Award

Teva Pharmaceuticals USA, INC.

Department of Defense · May 11, 2026 · FY2026

SPE2DP26F5471Set-aside not reportedNAICS 325412

Obligated

$515,290

Contract details

Award ID
CONT_AWD_SPE2DP26F5471_9700_SPE2DP20D0002_9700
PIID
SPE2DP26F5471
Period of performance
May 11, 2026 → May 19, 2026
Place of performance
PARSIPPANY, NJ, USA
Set-aside
Not reported
Pricing type
FIRM FIXED PRICE
PSC
6505 — DRUGS AND BIOLOGICALS
NAICS
325412 — PHARMACEUTICAL PREPARATION MANUFACTURING

Scope

8512097411!ADENOVIRUS TYPE 4 A

Parent vehicle (IDV)

Teva Pharmaceuticals USA, INC.

UEI NEN9A34LRHJ5

This award was placed as a task/delivery order under a larger contract vehicle.

Recipient

Teva Pharmaceuticals USA, INC. →
UEI
NEN9A34LRHJ5
CAGE
3V8D7
Parent
Teva Pharmaceuticals USA, INC.
Address
NORTH WALES, PA

Awarding agency

Department of Defense →
Sub-agency
Defense Logistics Agency
Office
DLA TROOP SUPPORT
Funding agency
Department of Defense
Funding office
DLA TROOP SUPPORT

See every contract Teva Pharmaceuticals USA, INC. has won

Full contracting history, year-over-year trends, subaward graph, and recompete alerts.

View Teva Pharmaceuticals USA, INC. profile →